News Focus
News Focus
Post# of 257262
Next 10
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 165939

Monday, 10/28/2013 2:07:48 PM

Monday, October 28, 2013 2:07:48 PM

Post# of 257262
Coherus/BAX announce positive PK study for Enbrel FoB, CHS-0214:

http://finance.yahoo.com/news/coherus-announces-chs-0214-proposed-115900393.html

CHS-0214 is being developed for the EU, Canada, Brazil, and other emerging markets.

(In the US, AMGN’s patent protection precludes an FoB until 2028, until the patent is successfully challenged: #msg-69263618.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now